Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
Rev Sci Instrum ; 92(6): 064101, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-34243508

ABSTRACT

With the aim of improving phototherapy for neonatal jaundice (hyperbilirubinemia), this study investigates the degradation of unconjugated bilirubin under irradiance by conventional light and by white, red, green, and blue LED sources in vitro. The absorption spectra of bilirubin under these different light sources are compared. The results demonstrate that white LED phototherapy promotes more efficient bilirubin degradation than conventional blue-light therapy. This study provides a basis for the design of novel phototherapy devices for the treatment of hyperbilirubinemia.


Subject(s)
Jaundice, Neonatal , Phototherapy , Bilirubin , Humans , Infant, Newborn , Light
2.
J Neuroendocrinol ; 28(9)2016 09.
Article in English | MEDLINE | ID: mdl-27328988

ABSTRACT

The choroid plexus (CP) epithelium is a unique structure in the brain that forms an interface between the peripheral blood on the basal side and the cerebrospinal fluid (CSF) on the apical side. It is a relevant source of many polypeptides secreted to the CSF with neuroprotective functions and also participates in the elimination and detoxification of brain metabolites, such as ß-amyloid (Aß) removal from the CSF through transporter-mediated influx. The CP is also a target tissue for sex hormones (SHs) that have recognised neuroprotective effects against a variety of insults, including Aß toxicity and oxidative stress in the central nervous system. The present study aimed to understand how SHs modulate Aß-induced oxidative stress in a CP cell line (Z310 cell line) by analysing the effects of Aß1-42 on oxidative stress, mitochondrial function and apoptosis, as well as by assessing how 17ß-oestradiol (E2 ) and 5α-dihydrotestosterone (DHT) modulated these effects and the cellular uptake of Aß1-42 by CP cells. Our findings show that E2 and DHT treatment reduce Aß1-42 -induced oxidative stress and the internalisation of Aß1-42 by CP epithelial cells, highlighting the importance of considering the background of SHs and therefore sex-related differences in Aß metabolism and clearance by CP cells.


Subject(s)
Amyloid beta-Peptides/metabolism , Choroid Plexus/metabolism , Gonadal Steroid Hormones/metabolism , Oxidative Stress , Peptide Fragments/metabolism , 5-alpha-Dihydroprogesterone/metabolism , Amyloid beta-Peptides/toxicity , Animals , Apoptosis , Cell Line , Choroid Plexus/drug effects , Electron Transport Complex IV/metabolism , Estradiol/metabolism , Neuroprotective Agents , Peptide Fragments/toxicity , Prealbumin/metabolism , Rats, Wistar , Reactive Oxygen Species , Receptors, Estrogen/metabolism
3.
Climacteric ; 19(3): 299-302, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27031181

ABSTRACT

Objective To evaluate the effect of short-term hormone replacement therapy with tibolone 2.5 mg daily on endothelial function of healthy postmenopausal women, using flow-mediated dilation (FMD) of the brachial artery. Methods We performed a randomized, double-blinded, placebo-controlled study. A total of 100 healthy postmenopausal women were randomly allocated to receive tibolone (n = 50) or placebo (n = 50) for 28 days. Measurement of the FMD of the brachial artery was performed before and after the use of tibolone and placebo. Results A total of 31 women completed the study in the tibolone group, and 32 women completed the study in the control group. The results of the FMD measurements obtained from the women in the two groups before treatment were similar (0.018 and 0.091, for tibolone and placebo, p = 0.57). The values of the FMD in women who used tibolone and placebo, before and after the treatment, were similar in both groups. The numbers of women who presented an increase in the values of the FMD in both groups were also similar. Conclusion Our results demonstrate that the administration of 2.5 mg tibolone to healthy postmenopausal women for 28 days does not promote endothelial-dependent vasodilation, measured by FMD of the brachial artery.


Subject(s)
Endothelium, Vascular/drug effects , Endothelium, Vascular/physiology , Estrogen Receptor Modulators , Norpregnenes/administration & dosage , Brachial Artery/physiology , Double-Blind Method , Female , Hormone Replacement Therapy , Humans , Middle Aged , Norpregnenes/adverse effects , Placebos , Postmenopause , Prospective Studies , Vasodilation/drug effects
4.
Scand J Med Sci Sports ; 26(9): 1109-16, 2016 Sep.
Article in English | MEDLINE | ID: mdl-26369504

ABSTRACT

The pelvic floor (PF) provides support to all pelvic organs, as well as appropriately closure/opening mechanism of the urethra, vagina, and anus. Therefore, it is likely that female athletes involved in high-impact and in strong-effort activities are at risk for the occurrence of urinary incontinence (UI). This study aimed to investigate the occurrence of UI and other PF dysfunctions (PFD) [anal incontinence (AI), symptoms of constipation, dyspareunia, vaginal laxity, and pelvic organ prolapse] in 67 amateur athletes (AT) compared with a group 96 of nonathletes (NAT). An ad hoc survey based on questions from reliable and valid instruments was developed to investigate the occurrence of PFD symptoms. The risk of UI was higher in AT group (odds ratio: 2.90; 95% CI: 1.50-5.61), mostly among artistic gymnastics and trampoline, followed by swimming and judo athletes. Whereas, AT group reported less straining to evacuate (OR: 0.46; 95% CI: 0.22-0.96), manual assistance to defecate (OR: 0.24; 95% CI: 0.05-1.12), and a higher stool frequency (OR: 0.29; 95% CI: 0.13-0.64) than NAT group. The occurrence of loss of gas and sexual symptoms was high for both groups when compared with literature, although with no statistical difference between them. Pelvic organ prolapse was only reported by nonathletes. Athletes are at higher risk to develop UI, loss of gas, and sexual dysfunctions, either practicing high-impact or strong-effort activities. Thus, pelvic floor must be considered as an entity and addressed as well. Also, women involved in long-term high-impact and strengthening sports should be advised of the impact of such activities on pelvic floor function and offered preventive PFD strategies as well.


Subject(s)
Constipation/epidemiology , Dyspareunia/epidemiology , Fecal Incontinence/epidemiology , Pelvic Organ Prolapse/epidemiology , Sports/statistics & numerical data , Urinary Incontinence/epidemiology , Adolescent , Adult , Brazil/epidemiology , Cross-Sectional Studies , Female , Gymnastics/statistics & numerical data , Health Surveys , Humans , Martial Arts/statistics & numerical data , Swimming/statistics & numerical data , Volleyball/statistics & numerical data , Young Adult
5.
Scand J Immunol ; 82(2): 135-41, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25969863

ABSTRACT

Diabetic nephropathy (DN) is a common complication in patients with diabetes, and most of them need renal replacement therapy such as haemodialysis (HD). These patients have a high tendency to develop infections and exhibit anomalies in the immune system. The objective of this study was to assess the expression of activation-related markers on T cells, as well as to quantify inflammatory cytokines, before and after a single HD session in DN patients. The study involved DN patients under HD treatment who signed an informed consent form. Blood samples before and after one HD session were collected, to analyse the expression of CD25, CD69 and CD71 in T cells. We also quantified IL-12p70, IL-8, IL-10, IL-1ß, TNF-α and IL-6 in serum samples using the cytometric bead array technique. After the HD session, there was an increase in the CD4/CD8 ratio due to significant alterations in both subsets. The relative percentage of CD25+ cells and CD8+ CD25+ increased significantly after the HD session, while the relative percentage of CD69 T cells decreased. There was a significant decrease in the CD25 mean fluorescence intensity values for CD4+ T, as well as in the case of CD71 in T cells after the HD session. Regarding cytokine synthesis, we found a significant increase in IL-10 and IL-6 and a decrease in IL-8 after HD session. This study showed that a HD session in DN patients affects the T cell activation status in the two major subpopulations and differentially modulates the production of inflammatory cytokines.


Subject(s)
Cytokines/blood , Diabetes Mellitus/blood , Lymphocyte Activation/immunology , T-Lymphocytes/immunology , Aged , Antigens, CD/blood , Antigens, CD/immunology , CD4-CD8 Ratio , Cytokines/immunology , Diabetes Mellitus/immunology , Diabetic Nephropathies/blood , Female , Humans , Male , Renal Dialysis
6.
Article in English | MEDLINE | ID: mdl-25812709

ABSTRACT

AIM: Attraction to physical activity (PA) is an important contributor to children´s intrinsic motivation to engage in games, and sports. Previous studies have supported the utility of the children´s attraction to PA scale (CAPA) (Brustad, 1996) but the validity of this measure for use in Portugal has not been established. The purpose of this study was to cross-validate the shorter version of the CAPA scale in the Portuguese cultural context. METHODS: A sample of 342 children (8--10 years of age) was used. Confirmatory factor analyses using EQS software ( version 6.1) tested t hree competing measurement models: a single--factor model, a five factor model, and a second order factor model. RESULTS: The single--factor model and the second order model showed a poor fit to the data. It was found that a five-factor model similar to the original one revealed good fit to the data (S--B χ 2 (67) =94.27,p=0.02; NNFI=0.93; CFI=0.95; RMSEA=0.04; 90%CI=0.02;0.05). CONCLUSIONS: The results indicated that the CAPA scale is valid and appropriate for use in the Portuguese cultural context. The availability of a valid scale to evaluate attraction to PA at schools should provide improved opportunities for better assessment and understanding of children´s involvement in PA.

7.
Arq. bras. med. vet. zootec ; 65(1): 301-307, fev. 2013. tab
Article in English | LILACS | ID: lil-667570

ABSTRACT

Diflubenzuron (DFB) is used to control ectoparasitic infestation by inhibiting larvae development in the manure and feces of treated animals. It is also currently been used to control tick infestations. In this study, milk and tissues from cattle treated orally with DFB for a 77-120 day period with a commercial product containing the compound were analyzed for the presence of residues. DFB residues were determined by using extraction with acetonitrile, cleanup with C18 SPE and chromatographic analysis by HPLC with UV detection (254nm). DFB was not detected in any of the analysed samples (<0.006mg kg-1 for fat, <0.014mg kg-1 for muscle, <0.015mg kg-1 for kidney, <0.016mg kg-1 for liver and <0.0006mg kg-1 for milk). In this manner, the use of this compound, according to the manufacturer's suggested doses may result in cattle milk, liver, kidneys, fat and muscles being considered safe regarding the presence of DFB residues.


O diflubenzuron (DFB) é um inibidor de desenvolvimento de insetos que inibe a síntese de quitina com atividade ovicida e larvicida e está sendo utilizado na pecuária para o controle do carrapato. Leite e tecidos provenientes de bovinos tratados por um período de 77 a 120 dias com um produto comercial contendo DFB foram analisados quanto à presença de resíduos. Os resíduos de DFB foram determinados utilizando-se extração com acetonitrila, limpeza por SPE C18 e cromatografia líquida de alta eficiência com detecção por UV (254nm). DFB não foi detectado em nenhuma das amostras analisadas (<0.006mg kg-1 para gordura, <0,014mg kg-1 para músculo, <0,015mg kg-1 para rim, <0,016mg kg-1 para fígado e <0.0006mg kg-1 para leite). Dessa forma, a utilização do princípio ativo conforme recomendado pelo fabricante e em níveis suficientes para se obter o efeito larvicida desejado deve resultar em leite, fígado, rins, gordura e músculos que podem ser considerados seguros para o consumo em termos da presença DFB.


Subject(s)
Animals , Cattle , Diflubenzuron/administration & dosage , Diflubenzuron/chemistry , Diflubenzuron/chemical synthesis , Epidermis/abnormalities , Epidermis , Insecta/cytology , Insecta/chemistry
8.
J Nanosci Nanotechnol ; 12(8): 6804-10, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22962826

ABSTRACT

Polymer based composites of a-PVDF doped with different NaY zeolite (Na53Al53Si139O384) content were investigated. A good dispersion of NaY zeolite within the polymer matrix is achieved. The introduction of NaY nanoparticles enhance the storage modulus and the dielectric constant at room temperature. The dielectric constant at room temperature increases up to the value of 500 for the 32 wt% composite, at 1 kHz. The increase of the dielectric constant is mainly attributed to interfacial polarization effects. For increasing zeolite content, the nanocomposite conductivity shows two conducting regimes separted by the so called breaking voltage, which is associated to an intrazeolite charge transport. Thermogravimetric results show that the introduction of zeolites affects the thermal degradation of the polymer for low zeolite contents and also indicate the presence of water that also plays an important role in the electrical response of the materials.

9.
Int J Immunogenet ; 39(4): 357-61, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22360648

ABSTRACT

We investigated the association between MBL2 gene exon 1 functional polymorphisms and autoimmune thyroid disease (AITD) in 163 Brazilian patients (87 with Hashimoto thyroiditis, HT; 76 with Graves' disease) and 214 healthy controls. Individuals carrying MBL2 O allele are at higher risk of developing AITD (OR = 1.58, 95% CI: 1.11-2.26; P-value = 0.009) and HT (OR = 1.67, 95% CI: 1.09-2.55; P-value = 0.013) as suggesting a possible role for mannose-binding lectin in influencing disease susceptibility.


Subject(s)
Exons , Graves Disease/genetics , Hashimoto Disease/genetics , Mannose-Binding Lectin/genetics , Adolescent , Adult , Brazil/epidemiology , Case-Control Studies , Child , Child, Preschool , Female , Genetic Association Studies , Genetic Predisposition to Disease , Genetic Testing , Graves Disease/epidemiology , Hashimoto Disease/epidemiology , Humans , Infant , Male , Middle Aged , Polymorphism, Single Nucleotide , Young Adult
10.
Climacteric ; 14(4): 492-6, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21426232

ABSTRACT

OBJECTIVE: To evaluate the effectiveness and safety of cinnarizine in the treatment of menopausal symptoms. DESIGN: A total of 100 climacteric and symptomatic women participated in a double-blind, placebo-controlled study. They were divided into two groups of the same size: Gcin, intake of 25 mg of cinnarizine every 12 h for 6 months (n=50); and Gpla, placebo intake every 12 hours for 6 months (n=50). Menopausal symptoms were evaluated according to the Kupperman menopausal index on the first visit and at 6 months of treatment. A total of 62 women completed the study: 27 from the Gcin group and 35 from the Gpla group. RESULTS: Based on the Kupperman menopausal index, there were no statistically significant differences between the two groups before and after the treatment. CONCLUSION: Our data suggest cinnarizine is not effective on menopausal symptoms because it had no more efficacy than placebo.


Subject(s)
Cinnarizine/therapeutic use , Histamine H1 Antagonists/therapeutic use , Menopause , Aged , Cinnarizine/adverse effects , Double-Blind Method , Female , Hot Flashes/drug therapy , Humans , Middle Aged , Placebos , Sexual Dysfunction, Physiological/drug therapy , Vaginal Diseases/drug therapy
11.
Climacteric ; 13(2): 179-86, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19657792

ABSTRACT

OBJECTIVE: To evaluate liver function and hemostatic parameters in postmenopausal women who have chronic infection with the hepatitis C virus and climacteric symptoms and are undergoing hormone therapy (HT) (standard dose of transdermal continuous combined hormone therapy). DESIGN: Fifty out of 336 postmenopausal patients with chronic infection with the hepatitis C virus were selected. The non-inclusion criteria were other chronic or systemic liver diseases, severe vascular diseases, autoimmune diseases or malignant tumors. The patients were randomized into two groups: the HT group with 25 patients to be given transdermal hormone therapy (50 microg estradiol plus 170 microg norethisterone/day) and the control group with the other 25 patients (no medication). Hepatic tests (alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase, total alkaline phosphatase, albumin, serum bilirubin) and hemostatic parameters (prothrombin time, factor V, fibrinogen) were evaluated at baseline and at 1, 4, 7 and 9 months of treatment. RESULTS: No significant changes in parameters were found in the comparison between the treated group and the controls, except for a decrease in total alkaline phosphatase (p = 0.002), presumably due to changes in bone remodelling. CONCLUSIONS: There were no changes in liver function after a 9-month treatment with transdermal estradiol plus norethisterone in symptomatic postmenopausal patients with hepatitis C.


Subject(s)
Estrogen Replacement Therapy , Hepatitis C, Chronic/physiopathology , Liver/drug effects , Liver/physiology , Administration, Cutaneous , Alanine Transaminase/metabolism , Alkaline Phosphatase/metabolism , Aspartate Aminotransferases/metabolism , Brazil , Climacteric/drug effects , Female , Hepatitis C, Chronic/enzymology , Humans , Liver/enzymology , Middle Aged , Pilot Projects , Postmenopause/metabolism , Serum Albumin/metabolism , gamma-Glutamyltransferase/metabolism
12.
Climacteric ; 11(1): 17-25, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18202961

ABSTRACT

OBJECTIVE: To evaluate the effect of the addition of methyltestosterone to estrogen and progestogen therapy on postmenopausal sexual energy and orgasm. METHODS: Sixty postmenopausal women in a stable relationship with a partner capable of intercourse, and presenting sexual complaints that appeared after menopause, were randomly divided into two groups: EP (n = 29) received one tablet of equine estrogens (CEE) 0.625 mg plus medroxyprogesterone acetate (MPA) 2.5 mg and one capsule of placebo; EP + A (n = 31) received one tablet of CEE 0.625 mg plus MPA 2.5 mg and one capsule of methyltestosterone 2.0 mg; The treatment period was 12 months. The effects of treatment on sexual energy were assessed using the Sexual Energy Change Scale. The ability to reach orgasm in sexual relations with the partner was verified through monthly calendars and by calculating the ratio between monthly frequency of orgasms in sexual relations and monthly sexual frequency. RESULTS: There was a significant relationship between improvement in level of sexual energy and the addition of methyltestosterone to CEE/MPA treatment (p = 0.021). No significant effect on orgasmic capacity was noted after the treatment period. CONCLUSION: Addition of methyltestosterone to CEE/MPA therapy may increase sexual energy, but might not affect the ability to obtain orgasm in sexual relations.


Subject(s)
Estrogen Replacement Therapy , Estrogens/pharmacology , Libido/drug effects , Methyltestosterone/pharmacology , Orgasm/drug effects , Progestins/pharmacology , Adult , Cohort Studies , Double-Blind Method , Estrogen Receptor Modulators/metabolism , Estrogen Replacement Therapy/adverse effects , Estrogen Replacement Therapy/methods , Estrogens/blood , Estrogens, Conjugated (USP) , Female , Humans , Libido/physiology , Middle Aged , Orgasm/physiology , Postmenopause , Progestins/blood
13.
Int Endod J ; 41(4): 329-38, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18217988

ABSTRACT

AIM: To correlate the mechanical behaviour in torsion, bending and fatigue tests of K3 instruments with their dimensional characteristics. METHODOLOGY: Instrument length, tip angle, distance between blades (pitch length) and the diameter at each millimetre from the tip of sizes 20, 25 and 30, 0.04 taper and sizes 20 and 25, 0.06 taper K3 rotary instruments were measured in an optical microscope equipped with digital micrometers. The cross-sectional area at 3 mm from the tip of the same instruments was determined using digital image analysis of scanning electron microscopy images. Maximum torque and angular deflection, as well as bending moment at 45 degrees were measured according to specification of ISO 3630-1. Fatigue resistance of instruments size 30, 0.04 taper, and sizes 20 and 25, 0.06 taper was determined in a fatigue test bench device. RESULTS: The analysed instruments presented no uniformity in the distance between adjacent blades, but the measured diameters at each millimetre from the tip were regular, showing compliance with manufacturing standards. Torque and bending moment of the tested instruments increased significantly with diameter and cross-sectional area at 3 mm from the instrument tip. The fatigue resistance of the instruments showed a tendency to decrease as the diameter of the instruments increased. CONCLUSIONS: The bending moment at 45 degrees and the torsional resistance of K3 instruments can be predicted using instrument diameter and cross-sectional area at 3 mm from the tip. Fatigue resistance decreased as the instrument diameter increased.


Subject(s)
Dental Instruments , Root Canal Preparation/instrumentation , Analysis of Variance , Dental Alloys , Dental Stress Analysis , Elasticity , Equipment Design , Equipment Failure , Nickel , Pliability , Titanium , Torque
14.
Allergol Immunopathol (Madr) ; 35(5): 177-83, 2007.
Article in English | MEDLINE | ID: mdl-17923071

ABSTRACT

BACKGROUND: Asthma is a heterogeneous chronic inflammatory condition characterised by reversible airway obstruction and hyperresponsiveness associated with underlying bronchial inflammation and structural changes. It represents an increasing health problem and is a huge burden on the patients, their families and society. The aim of the study was to characterise the adult asthmatic population attending a Hospital Allergy Clinic between the years of 2003 and 2006. METHODS: Clinical files from the Allergy Outpatient Clinic of Cova da Beira Hospital were sequentially studied. The total population analysed included 335 female and 130 male asthmatic patients. Bronchial asthma was characterised by clinical history, skin prick testing to aeroallergens, determination of total and specific IgE and lung function testing, and classified according to international guidelines. RESULTS: Of the patients studied, 70 % had allergic asthma, and 30 % had non-allergic asthma. When compared to allergic asthma, non-allergic asthma was more frequently associated with older age, perennial symptoms and female gender. More allergic than non-allergic asthma patients also had rhinitis and the reverse was true regarding drug allergy and oesophageal reflux. Grass pollen and mites were the major sensitisers for allergic asthmatics. The sensitisation profile was significantly different between urban- and rural-based asthmatic patients regarding tree pollen, fungi and moulds. CONCLUSIONS: In this population, rhinitis was more frequently associated with allergic than with non-allergic asthma. The two types of asthma did not differ in clinical severity or changes in lung function. Sensitisation profiles were different between the urban and rural patients.


Subject(s)
Asthma/epidemiology , Respiratory Hypersensitivity/diagnosis , Respiratory Hypersensitivity/epidemiology , Rhinitis, Allergic, Perennial/epidemiology , Adult , Asthma/complications , Asthma/diagnosis , Disease Susceptibility , Female , Humans , Male , Portugal/epidemiology , Respiratory Hypersensitivity/complications , Rhinitis, Allergic, Perennial/complications , Rhinitis, Allergic, Perennial/diagnosis , Rural Population , Urban Population
16.
Clin Drug Investig ; 27(2): 131-7, 2007.
Article in English | MEDLINE | ID: mdl-17217318

ABSTRACT

OBJECTIVE: This study aimed to evaluate the effects of monophasic estrogen-progestogen therapy on the sexuality and climacteric symptoms of postmenopausal women. PATIENTS AND METHODS: A prospective, randomised, double-blind, crossover, placebo-controlled, single-centre study was carried out over a total of 12 consecutive months in 40 postmenopausal women with an intact uterus who had no contraindications to hormone therapy. Patients received 17beta-estradiol 2mg in combination with norethisterone acetate 1mg (Cliane) daily for 6 months or one placebo tablet daily for 6 months. The tablets were identical in appearance. After 6 months, the groups were crossed over and the patients were followed up for another 6 months. The groups were homogenous with respect to age, height, bodyweight, body mass index and race. For the statistical analysis, the group receiving hormone therapy was referred to as group A and the placebo group was designated group B, irrespective of the placebo/hormone therapy sequence. RESULTS: In group A there were fewer hot flashes (F=22.85, p<0.01) and an improvement in sexual interest (F=5.55, p<0.05). The sequence in which the medication was received resulted in a statistically significant difference with respect to dyspareunia (F=9.65, p<0.01) and satisfaction with the duration of penetration (F=6.58, p<0.05). In the intrapatient analysis of variation with respect to orgasmic capability and the presence of dialogue with partner regarding the couple's sexual life, whether the placebo was taken prior to or following hormone therapy was significant (F=17.12, p<0.001 and F=7.10, p<0.05, respectively). CONCLUSIONS: Monophasic estrogen-progestogen therapy has a beneficial effect on sexuality and on hot flashes in postmenopausal women.


Subject(s)
Estradiol/therapeutic use , Hormone Replacement Therapy , Norethindrone/analogs & derivatives , Postmenopause/drug effects , Adult , Cross-Over Studies , Double-Blind Method , Drug Combinations , Female , Hot Flashes/drug therapy , Humans , Libido/drug effects , Middle Aged , Norethindrone/therapeutic use , Norethindrone Acetate , Personal Satisfaction , Postmenopause/physiology , Progesterone Congeners/therapeutic use
17.
Allergol Immunopathol (Madr) ; 34(6): 234-41, 2006.
Article in English | MEDLINE | ID: mdl-17173839

ABSTRACT

BACKGROUND: CD8+ T suppressor cells may play a role in immunoregulation. Recent studies have characterized this population by the lack of the CD28 molecule. These CD8+CD28 T cells differ phenotypically and functionally from CD8 + CD28 + T cells. Little is known about CD8 + CD28 cells in atopy. Our aim was to analyze the phenotype and functional properties of CD8 + CD28T cells in atopic and non-atopic individuals. METHODS: Peripheral blood mononuclear cells (PBMC) were obtained after density gradient centrifugation. CD8 + CD28 and CD8 + CD28 + T cells were isolated using immunomagnetic beads. Relative percentages of these cells and expression of several phenotypic markers were analyzed by flow cytometry. Proliferation was assessed by thymidine incorporation in isolated populations and in co-cultures with PBMC using Dermatophagoides pteronyssinus as stimulus. Cytokine synthesis was evaluated in culture supernatants by cytometric bead array. RESULTS: The relative percentages of CD8+CD28 T cells and their phenotypic expression in atopic and non-atopic volunteers were not significantly different. However, CD8 + CD28 T cells showed greater proliferation than did CD8+CD28+ T cells when stimulated with D. pteronyssinus, although cytokine synthesis patterns were similar. CD8+CD28 co-cultures with PBMC showed greater proliferation than CD8+CD28+ T cell co-cultures, but cytokine synthesis patterns were not different. CONCLUSIONS: Our data confirm phenotypic and functional differences between CD28+ and CD28 T cells, irrespective of atopic status. Purified human CD8+CD28 T cells, freshly isolated from peripheral blood, do not have suppressor properties on allergen-specific proliferation or on cytokine synthesis in PBMC.


Subject(s)
Antigens, Dermatophagoides/adverse effects , CD28 Antigens/analysis , CD8-Positive T-Lymphocytes/immunology , Dermatophagoides pteronyssinus/immunology , Hypersensitivity, Immediate/immunology , Rhinitis, Allergic, Perennial/immunology , T-Lymphocyte Subsets/immunology , Adult , Animals , Antigen-Presenting Cells/immunology , CD8-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/pathology , Cells, Cultured/drug effects , Cells, Cultured/immunology , Cells, Cultured/metabolism , Coculture Techniques , Cytokines/metabolism , Female , Flow Cytometry , Humans , Hypersensitivity, Immediate/etiology , Immunomagnetic Separation , Immunophenotyping , Lymphocyte Activation , Male , Muromonab-CD3/pharmacology , Receptors, Antigen, T-Cell, alpha-beta/analysis , Receptors, Antigen, T-Cell, gamma-delta/analysis , Rhinitis, Allergic, Perennial/etiology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/pathology
19.
Anthropol Anz ; 61(3): 297-310, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14524003

ABSTRACT

Group differences in symptomatology and symptom perception of young women ageing between 18 and 32 years suffering from polycystic ovarian syndrome (PCOS) were tested according to cultural background and weight status. In detail 31 Austrian women, living in Carinthia, Austria, and 102 Brazilian women, living in São Paulo, Brazil, were enrolled in the present study. All participants suffered from diagnosed PCOS. The prevalence of hirsutism, infertility, menstrual disturbances and overweight/obesity and their individual impact on health related quality of life were analysed. Furthermore the impact of weight status (BMI) on symptom perception was tested. It turned out, that the Brazilian sample exhibited higher prevalence of PCOS symptoms and these symptoms had a more negative impact on quality of life. The only exception was body weight. Although significantly leaner, the Austrian women showed a higher Cronin score of body weight than their Brazilian counterparts. The results of the present study may indicate that in western industrialized societies the fear of overweight is much more prevalent than in a developing country such as Brazil and thus it has more influence on the quality of life than all the other symptoms.


Subject(s)
Body Mass Index , Phobic Disorders/epidemiology , Phobic Disorders/psychology , Polycystic Ovary Syndrome/epidemiology , Polycystic Ovary Syndrome/psychology , Quality of Life/psychology , Self Concept , Adolescent , Adult , Austria/epidemiology , Brazil/epidemiology , Comorbidity , Female , Hirsutism/epidemiology , Humans , Obesity/epidemiology , Phobic Disorders/ethnology , Polycystic Ovary Syndrome/ethnology , Prevalence
20.
Climacteric ; 6(4): 321-9, 2003 Dec.
Article in English | MEDLINE | ID: mdl-15006253

ABSTRACT

OBJECTIVE: To assess the influence of psychosocial factors, behavior and hormones on postmenopausal sexuality. METHODS: Nine hundred and ninety-nine women (age range 41-60 years) underwent physical and supplementary tests and answered questionnaires regarding sexual behavior. Sixty healthy women with 1 or more years of amenorrhea, without hormone replacement therapy and with a partner capable of intercourse were chosen from this group. Logistic regression models with dependent variables (sexual satisfaction and orgasmic capacity) and independent variables (sexual initiation, psychosocial factors, behavior, relationship, menopause and hormones) were developed. RESULTS: Important variables for sexual satisfaction were: good self-esteem (p< 0.01), first orgasm obtained by masturbation (p = 0.004), major personal income (p = 0.007), sexual initiation in adulthood (p = 0.008), value physical contact with partner (p = 0.021) and major orgasmic capacity p = 0.040). The following contributed (towards orgasmic capacity with the partner: sexual initiation in adulthood (p = 0.012), regular physical activity (p = 0.040) and higher testosterone levels (p = 0.050). CONCLUSIONS: The importance of relationship, psychological, hormonal, economic and behavioral factors confirm the complexity of sexuality, and we note that current as well as prior events seem to affect the sexual satisfaction and orgasmic capacity of healthy postmenopausal women.


Subject(s)
Postmenopause , Sexuality , Adult , Age Factors , Female , Humans , Logistic Models , Middle Aged , Motor Activity , Self Concept , Sexual Behavior , Sexual Partners , Socioeconomic Factors , Surveys and Questionnaires , Testosterone/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...